Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00326339
Status:
COMPLETED
Last Update Posted:
2009-04-20
First Post:
2006-05-12
Brief Title:
Treatment of Arthritis With Syk Kinase Inhibition TASKI-1
Sponsor:
Rigel Pharmaceuticals
Organization:
Rigel Pharmaceuticals
Organization Data
Organization:
Rigel Pharmaceuticals
Class:
INDUSTRY
Study ID:
C-935788-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rigel Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Elliott GrossbardSVP Medical Development
Old Organization:
Rigel Pharmaceuticals Inc